ADTX

Companies
NASDAQ
Aditxt Inc.
Health Care
Price Chart
Overview

About ADTX

a biotech company with a mission to accelerate humanity’s transition to the 'age of immunity', we are the business busily decoding the human immune system.

Market Cap
$3.2M
Volume
286.4K
Avg. Volume
7.8M
P/E Ratio
-0.3326838
Dividend Yield
0.00%
Employees
44.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.65
Low Correlation
Volatility
High (1.00)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for ADTX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, ADTX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$3.2M
Volume286.4K
P/E Ratio-0.33
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
April 15, 2025

PortfolioPilot Analysis

Get AI-powered insights on how ADTX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025